Aethlon Medical shares are trading higher after the company announced results from an in vitro binding study of its Hemopurifier in removing extracellular vesicles from plasma.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.